Jefferies Financial Group’s Bio-Rad Laboratories Class A BIO Stock Holding History

Jefferies Financial Group’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,445	Closed	-$438K	–	1757
2025 Q4	$438K	Buy	+1,445	New	+$451K	﹤0.01%	1372
2025 Q3	–	Sell	-3,300	Closed	-$796K	–	1462
2025 Q2	$796K	Buy	+3,300	New	+$780K	0.01%	792
2025 Q1	–	Sell	-1,807	Closed	-$594K	–	1636
2024 Q4	$594K	Sell	1,807 -5,258	-74%	-$1.78M	﹤0.01%	1063
2024 Q3	$2.36M	Buy	+7,065	New	+$2.24M	0.02%	543
2024 Q2	–	Sell	-695	Closed	-$240K	–	1428
2024 Q1	$240K	Sell	695 -1,305	-65%	-$429K	﹤0.01%	1284
2023 Q4	$646K	Buy	2,000 +1,265	+172%	+$396K	﹤0.01%	1116
2023 Q3	$263K	Sell	735 -200	-21%	-$77.2K	﹤0.01%	1266
2023 Q2	$354K	Sell	935 -9,065	-91%	-$3.69M	﹤0.01%	1277
2023 Q1	$4.79M	Sell	10,000 -6,527	-39%	-$3.06M	0.04%	375
2022 Q4	$6.95M	Buy	+16,527	New	+$6.67M	0.05%	307

Other funds holding BIO

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Jefferies Financial Group's BIO Position: Q1 2026 in Review

Jefferies Financial Group sold out of Bio-Rad Laboratories Class A (BIO) in Q1 2026, closing a stake of 1,445 shares — an estimated $438K sold.

Jefferies Financial Group first reported a position in BIO in Q4 2022 and held it in 10 quarters. The position peaked at $6.95M in Q4 2022. 395 funds tracked by Wall St. Rank hold BIO as of Q1 2026.

Jefferies Financial Group reported no remaining Bio-Rad Laboratories Class A position as of Q1 2026 after selling out during the quarter.
Jefferies Financial Group sold 1,445 Bio-Rad Laboratories Class A shares in Q1 2026, an estimated $438K.
Jefferies Financial Group first reported a position in Bio-Rad Laboratories Class A in Q4 2022 and held it in 10 quarters.
Jefferies Financial Group's Bio-Rad Laboratories Class A position peaked at $6.95M in Q4 2022.
395 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2026.

Based on Jefferies Financial Group's 13F filing for Q1 2026, filed 8 May 2026.